Atlas Trials

Use of Gastrografin in the Management of Fecal Impaction in Patients With Severe Chronic Constipation

Clinical trial NCT02784093 · UNKNOWN

Trial details

NCT number
NCT02784093
Sponsor
Jinling Hospital, China
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Fecal Impaction
Start date
2015-04-01
Primary completion
2017-05-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.